Clinical Trial Update: Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma

View source ↗

Summary

A Stanford-led clinical trial investigating viral and host factors associated with HBV-related hepatocellular carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis C
• Hepatocellular Carcinoma

Snippet

Sponsor: Stanford University | Conditions: Liver Cancer, Hepatitis B | Status: TERMINATED